Skip to main content
Premium Trial:

Request an Annual Quote

Max Planck Institute to Use Waters Synapt HDMS to Study Protein Role in Brain Disease

NEW YORK (GenomeWeb News) - The Max Planck Institute of Biochemistry recently received one of Waters' mass spec systems, the Milford, Mass.-based company said Friday.
 
The Department of Cellular Biochemistry at the Martinsried, Germany-based institute will use the Synapt High Definition MS system to study the role of proteins in brain-wasting diseases such as Huntington's disease.
 
Manajit Hayer-Hartl, director and principal investigator for the department, said in a statement that the system will allow the researchers to characterize proteins of interest in great detail and said the ability to "separate species by ion mobility greatly enhances the appeal of this system."
 
Financial terms of the deal were not released.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.